Vitrolife's CEO Magnus Nilsson will leave the Group responsibility and focus on the Transplantation business

Vitrolife's CEO Magnus Nilsson will leave the Group responsibility and
focus on the Transplantation business

”During Magnus Nilsson's nine year as CEO, Vitrolife has reached the
three, early set, strategic objectives for the company's fertility
business; world leading production infrastructure, complete IVF product
portfolio and global sales organisation, which has made the company
world leading within the business of fertility treatment products,” says
Vitrolife's chairman Patrik Tigerschiöld. ”During Magnus' management the
stock value of Vitrolife has grown from approx SEK 150 million to almost
SEK 900 million, an increase of 500%”. After 35 quarters in a row with
sales growth and 33 with profit, whereof the last with record growth and
record strong operating income, Magnus will now resign as CEO. ”After
nine exciting and successful years in developing Vitrolife into a strong
corporation and after have reached the strategic targets set up at the
start of my tenure the timing seems right to now relay over to someone
new” says Magnus Nilsson.

Magnus, who has a long experience with the field of organ
transplantation, will now focus on leading Xvivo Perfusion AB, which
will be a more independent operating unit within the Vitrolife Group.
“The transplantation product area is now in an intensive and exciting
development phase, with decisive clinical trials and market
introductions. I see a large potential value in our transplantation
business which we will work hard to realize” says Magnus.

”Magnus knowledge about the research and commercial experience within
the field is extensive and he will, as soon as it is suitable, leave the
Vitrolife Group responsibility to focus on developing the
Transplantation product area to a therapeutically as well as a
commercial success” says Patrik Tigerschiöld.

The recruitment of a new head of the Fertility product area, also Group
CEO, will commence immediately.  

Gothenburg, October 31, 2011

VITROLIFE AB (publ)

Patrik
Tigerschiöld                                                      
Magnus Nilsson

Chairman of the Board                                                CEO

.

Queries should be addressed to:

Patrik Tigerschiöld, +46 8-614 00 22